Published in Crit Rev Oncol Hematol on July 10, 2006
Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol (2011) 1.09
Management of patients with vulvar cancer: a perspective review according to tumour stage. Ther Adv Med Oncol (2013) 0.97
A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma. Biomed Res Int (2014) 0.95
Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev (2011) 0.91
Multi-modality organ-based approach to expected imaging findings, complications and recurrent tumour in the genitourinary tract after radiotherapy. Insights Imaging (2013) 0.83
The first leg video endoscopic groin lymphadenectomy in vulvar cancer: A case report. Int J Surg Case Rep (2014) 0.81
Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside. J Transl Med (2012) 0.81
Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva. J Gynecol Oncol (2013) 0.81
Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol (2016) 0.78
Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma. Br J Cancer (2013) 0.78
Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas. Oncotarget (2016) 0.76
Vulva cancer in Ghana - Review of a hospital based data. Gynecol Oncol Rep (2017) 0.75
Surgical management for squamous cell carcinoma of vulva. Pan Afr Med J (2016) 0.75
Sentinel node procedure in vulvar carcinoma during pregnancy: A case report. Gynecol Oncol Case Rep (2012) 0.75
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis. Br J Cancer (2009) 1.53
[Surgical treatment of early-stage vulva carcinoma and the complications of the operation]. Ned Tijdschr Geneeskd (2005) 1.41
Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol (2010) 1.38
The clinical trail of TRAIL. Eur J Cancer (2006) 1.35
A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer (2012) 1.28
MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer (2007) 1.19
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol (2009) 1.16
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. Br J Cancer (2008) 1.15
Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study. Gynecol Oncol (2005) 1.08
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies. Br J Cancer (2006) 1.01
Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Gynecol Oncol (2007) 1.01
Risk factors for short- and long-term complications after groin surgery in vulvar cancer. Br J Cancer (2011) 1.00
Management of vulvar cancers. Eur J Surg Oncol (2006) 0.99
Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion. J Chromatogr A (2003) 0.99
Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int J Gynecol Cancer (2005) 0.96
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy. Int J Gynecol Cancer (2006) 0.95
Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer. Br J Cancer (2010) 0.95
Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study. Gynecol Oncol (2010) 0.94
Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis. J Chromatogr A (2006) 0.92
Patterns of care in surgery for ovarian cancer in Europe. Eur J Surg Oncol (2010) 0.92
A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol (2009) 0.92
Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis. Br J Cancer (2011) 0.92
Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer. Curr Cancer Drug Targets (2012) 0.91
Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL. Br J Cancer (2013) 0.90
EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction. Gynecol Oncol (2006) 0.89
Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer. Eur J Cancer (2009) 0.87
Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. J Med Genet (2005) 0.86
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. J Clin Pathol (2003) 0.86
A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer. Oncogene (2011) 0.85
Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer (2006) 0.84
A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma. Gynecol Oncol (2005) 0.83
Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer. Gynecol Oncol (2002) 0.83
A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer. Eur J Cancer (2005) 0.83
Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol (2009) 0.82
Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol (2004) 0.82
Loss of MSH2 protein expression is a risk factor in early stage cervical cancer. J Clin Pathol (2007) 0.81
Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies. Br J Pharmacol (2012) 0.81
Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage. Eur J Cancer (2004) 0.81
The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J Clin Pathol (2002) 0.81
Debulking surgery for ovarian epithelial cancer performed by a gynaecological oncologist improved survival compared with less specialised surgeons. Cancer Treat Rev (2006) 0.81
Immunologic aspect of ovarian cancer and p53 as tumor antigen. J Transl Med (2005) 0.80
A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer. J Proteome Res (2014) 0.79
Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma. Gynecol Oncol (2004) 0.79
No increased systemic fibrinolysis in women with heavy menstrual bleeding. J Thromb Haemost (2014) 0.78
Preoperative selection of patients with low-stage endometrial cancer at high risk of pelvic lymph node metastases. Int J Gynecol Cancer (2002) 0.78
Routine follow-up intervals in patients with high-grade squamous intraepithelial lesions (HSIL) and free excision margins can safely be increased in the first two years after Large Loop Excision of the Transformation Zone (LLETZ). Gynecol Oncol (2009) 0.77
Presentations of endometrial activity after curative radiotherapy for cervical cancer. Maturitas (2005) 0.77
Identification of inguinofemoral lymph node metastases by methylation markers in vulvar cancer. Gynecol Oncol (2012) 0.76
Groin surgery and the sentinel lymph node. Best Pract Res Clin Obstet Gynaecol (2003) 0.76
Tammussino et al.: groin recurrence after micrometastasis in a sentinel lymph node in a patient with vulvar cancer. Gynecol Oncol (2003) 0.75
[One hundred years of the Association of Surgeons in the Netherlands. VIII. Surgical oncology]. Ned Tijdschr Geneeskd (2002) 0.75
Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer. BJOG (2003) 0.75
Liver metastasis as a first sign of fallopian tube carcinoma and the role of positron emission tomography in preoperative diagnosis. Scand J Gastroenterol (2002) 0.75